WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE

Mark Identification

MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE

Click here to search for trademarks similar to MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE

Proof of use for MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE

We do not have any records of a proof of use for MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE at this moment.

Click here to add a proof of use for MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE

Possible trademark infringements of MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE

Basic Information about MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE

Serial Number
85294072
Filing Date
13 Apr 2011
Registration Number
4274072
Registration Date
15 Jan 2013
Mark Drawing Code
3

Classifications

Declare the trademark use of MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE on the blockchain with WikiTrademarks.io.

First use of MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE anywhere
MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE was first used on 03 Oct 2010 for the primary classification of goods and services, international, 035 (Advertising and business)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
035
US Codes
100; 101; 102

Who owns MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE?

Correspondent

John Paul Oleksiuk
Cooley LLP
1299 Pennsylvania Ave NW Ste 700
Washington DC 20004-2446